Item 1. Financial Statements (unaudited)

108K characters. Original on sec.gov · Markdown

Item 1. Financial Statements (unaudited)

Amcor plc and Subsidiaries

Condensed Consolidated Statements of Income

(Unaudited)

Three Months Ended December 31,Six Months Ended December 31,
($ in millions, except per share data)2023202220232022
Net sales$3,251$3,642$6,694$7,354
Cost of sales(2,630)(2,980)(5,428)(6,024)
Gross profit6216621,2661,330
Selling, general, and administrative expenses(299)(298)(601)(600)
Research and development expenses(28)(24)(55)(49)
Restructuring and other related activities, net(24)213(52)212
Other income/(expenses), net(28)6(46)8
Operating income242559512901
Interest income11112120
Interest expense(89)(79)(174)(138)
Other non-operating income, net13—3
Income before income taxes and equity in loss of affiliated companies165494359786
Income tax expense(28)(33)(67)(91)
Equity in loss of affiliated companies, net of tax(1)—(2)—
Net income$136$461$290$695
Net income attributable to non-controlling interests(2)(2)(4)(4)
Net income attributable to Amcor plc$134$459$286$691
Basic earnings per share:$0.093$0.309$0.198$0.465
Diluted earnings per share:$0.092$0.307$0.198$0.461

Note: Per share amounts may not add due to rounding. See accompanying notes to condensed consolidated financial statements.

Amcor plc and Subsidiaries

Condensed Consolidated Statements of Comprehensive Income

(Unaudited)

Three Months Ended December 31,Six Months Ended December 31,
($ in millions)2023202220232022
Net income$136$461$290$695
Other comprehensive income/(loss):
Net gains/(losses) on cash flow hedges, net of tax (a)243(3)
Foreign currency translation adjustments, net of tax (b)9914431(17)
Pension, net of tax (c)—(1)1(1)
Other comprehensive income/(loss)10114735(21)
Total comprehensive income237608325674
Comprehensive income attributable to non-controlling interests(2)(2)(4)(4)
Comprehensive income attributable to Amcor plc$235$606$321$670
(a) Tax benefit/(expense) related to cash flow hedges$(1)$—$(1)$1
(b) Tax benefit/(expense) related to foreign currency translation adjustments$3$2$2$(1)
(c) Tax benefit related to pension adjustments$—$—$—$—

See accompanying notes to condensed consolidated financial statements.

Amcor plc and Subsidiaries

Condensed Consolidated Balance Sheets

(Unaudited)

($ in millions, except share and per share data)December 31, 2023June 30, 2023
Assets
Current assets:
Cash and cash equivalents$430$689
Trade receivables, net of allowance for credit losses of $23 and $21, respectively1,8201,875
Inventories, net:
Raw materials and supplies941992
Work in process and finished goods1,2091,221
Prepaid expenses and other current assets559531
Total current assets4,9595,308
Non-current assets:
Property, plant, and equipment, net3,8103,762
Operating lease assets567533
Deferred tax assets130134
Other intangible assets, net1,4741,524
Goodwill5,3885,366
Employee benefit assets6867
Other non-current assets331309
Total non-current assets11,76811,695
Total assets$16,727$17,003
Liabilities
Current liabilities:
Current portion of long-term debt$12$13
Short-term debt4680
Trade payables2,3382,690
Accrued employee costs319396
Other current liabilities1,2551,297
Total current liabilities3,9704,476
Non-current liabilities:
Long-term debt, less current portion7,0116,653
Operating lease liabilities495463
Deferred tax liabilities609616
Employee benefit obligations207224
Other non-current liabilities408481
Total non-current liabilities8,7308,437
Total liabilities$12,700$12,913
Commitments and contingencies (See Note 14)
Shareholders' Equity
Amcor plc shareholders’ equity:
Ordinary shares ($0.01 par value)
Authorized (9,000 million shares)
Issued (1,445 and 1,448 million shares, respectively)$14$14
Additional paid-in capital3,9934,021
Retained earnings795865
Accumulated other comprehensive loss(827)(862)
Treasury shares (1 and 1 million shares, respectively)(11)(12)
Total Amcor plc shareholders' equity3,9644,026
Non-controlling interests6364
Total shareholders' equity4,0274,090
Total liabilities and shareholders' equity$16,727$17,003

See accompanying notes to condensed consolidated financial statements.

Amcor plc and Subsidiaries

Condensed Consolidated Statements of Cash Flows

(Unaudited)

Six Months Ended December 31,
($ in millions)20232022
Cash flows from operating activities:
Net income$290$695
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation, amortization, and impairment295284
Net periodic benefit cost74
Amortization of debt discount and deferred financing costs51
Net gain on disposal of property, plant, and equipment(1)(5)
Net gain on disposal of businesses—(219)
Equity in loss of affiliated companies2—
Net foreign exchange loss3525
Share-based compensation629
Other, net(47)11
Loss from highly inflationary accounting for Argentine subsidiaries8628
Deferred income taxes, net(5)(12)
Changes in operating assets and liabilities, excluding effect of acquisitions, divestitures, and currency(445)(696)
Net cash provided by operating activities228145
Cash flows from investing activities:
Issuance of loans to affiliated companies and other—(1)
Investments in affiliated companies and other(3)(49)
Business acquisitions(19)(54)
Purchase of property, plant, and equipment, and other intangible assets(245)(250)
Proceeds from divestitures—370
Proceeds from sales of property, plant, and equipment, and other intangible assets118
Net cash (used in)/provided by investing activities(256)24
Cash flows from financing activities:
Proceeds from issuance of shares—132
Purchase of treasury shares and tax withholdings for share-based incentive plans(51)(221)
Repayment of long-term debt(21)(11)
Net borrowing of commercial paper322500
Net repayment of short-term debt(44)(83)
Repayment of lease liabilities(6)(2)
Share buybacks/cancellations(30)(40)
Dividends paid(361)(365)
Net cash used in financing activities(191)(90)
Effect of exchange rates on cash and cash equivalents(40)(92)
Net decrease in cash and cash equivalents(259)(13)
Cash and cash equivalents balance at beginning of year689850
Cash and cash equivalents balance at end of period$430$837
Supplemental cash flow information:
Interest paid, net of amounts capitalized$162$127
Income taxes paid$124$91
Supplemental non-cash disclosures relating to investing and financing activities:
Purchase of property, plant, and equipment, accrued but unpaid$59$83
Contingent purchase considerations related to acquired businesses, accrued but not paid$27$12

See accompanying notes to condensed consolidated financial statements. Cash and cash equivalents at the beginning of fiscal year 2023 include cash and cash equivalents classified as held for sale.

Amcor plc and Subsidiaries

Condensed Consolidated Statements of Equity

(Unaudited)

($ in millions, except per share data)Ordinary SharesAdditional Paid-In CapitalRetained EarningsAccumulated Other Comprehensive LossTreasury SharesNon-controlling InterestsTotal
Balance as of September 30, 2022$15$4,412$588$(1,048)$(49)$58$3,976
Net income4592461
Other comprehensive income147—147
Share buyback/cancellations—(40)(40)
Dividends declared ($0.1225 per share)(181)(3)(184)
Options exercised and shares vested(14)5036
Net settlement of forward contracts to purchase own equity for share-based incentive plans, net of tax2020
Purchase of treasury shares(19)(19)
Share-based compensation expense1313
Change in non-controlling interests—11
Balance as of December 31, 2022$15$4,391$866$(901)$(18)$58$4,411
Balance as of June 30, 2022$15$4,431$534$(880)$(18)$59$4,141
Net income6914695
Other comprehensive loss(21)—(21)
Share buyback/cancellations—(40)(40)
Dividends declared ($0.2425 per share)(359)(6)(365)
Options exercised and shares vested(89)221132
Net settlement of forward contracts to purchase own equity for share-based incentive plans, net of tax6060
Purchase of treasury shares(221)(221)
Share-based compensation expense2929
Change in non-controlling interests—11
Balance as of December 31, 2022$15$4,391$866$(901)$(18)$58$4,411
Balance as of September 30, 2023$14$3,983$841$(928)$(12)$66$3,964
Net income1342136
Other comprehensive income101—101
Dividends declared ($0.125 per share)(180)(5)(185)
Shares vested(4)4—
Net settlement of forward contracts to purchase own equity for share-based incentive plans, net of tax33
Purchase of treasury shares(3)(3)
Share-based compensation expense1111
Balance as of December 31, 2023$14$3,993$795$(827)$(11)$63$4,027
Balance as of June 30, 2023$14$4,021$865$(862)$(12)$64$4,090
Net income2864290
Other comprehensive income35—35
Share buyback/cancellations—(30)(30)
Dividends declared ($0.2475 per share)(356)(5)(361)
Shares vested and related tax withholdings(52)49(3)
Net settlement of forward contracts to purchase own equity for share-based incentive plans, net of tax4848
Purchase of treasury shares(48)(48)
Share-based compensation expense66
Balance as of December 31, 2023$14$3,993$795$(827)$(11)$63$4,027

See accompanying notes to condensed consolidated financial statements.

Amcor plc and Subsidiaries

Notes to Condensed Consolidated Financial Statements

Note 1 - Nature of Operations and Basis of Presentation

Amcor plc ("Amcor" or the "Company") is a public limited company incorporated under the Laws of the Bailiwick of Jersey. The Company's history dates back more than 150 years, with origins in both Australia and the United States of America. Today, Amcor is a global leader in developing and producing responsible packaging for food, beverage, pharmaceutical, medical, home and personal-care, and other consumer goods end markets. The Company's innovation excellence and global packaging expertise enable the Company to solve packaging challenges around the world every day, producing packaging that is more functional, appealing, and cost effective for its customers and their consumers and importantly, more sustainable for the environment.

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States ("U.S. GAAP") for interim financial information. Consistent with these requirements, this Form 10-Q does not include all the information required by U.S. GAAP for complete financial statements. Further, the year-end condensed consolidated balance sheet data as of June 30, 2023 was derived from audited financial statements but does not include all disclosures required by U.S. GAAP. It is management's opinion, however, that all material and recurring adjustments have been made that are necessary for a fair statement of the Company's interim financial position, results of operations, and cash flows. For further information, this Form 10-Q should be read in conjunction with the audited consolidated financial statements and accompanying notes in the Company's Annual Report on Form 10-K for the fiscal year ended June 30, 2023.

There have been no material changes to the accounting policies followed by the Company during the current fiscal year. Certain amounts in the Company's notes to unaudited condensed consolidated financial statements may not add or recalculate due to rounding.

Note 2 - New Accounting Guidance

Recently Adopted Accounting Standards

In September 2022, the Financial Accounting Standards Board ("FASB") issued ASU 2022-04 that adds certain disclosure requirements for entities that use supplier finance programs in connection with the purchase of goods and services. The Company adopted the disclosure requirements in ASU 2022-04 on July 1, 2023, except for the amendment on roll forward information, which is effective in fiscal year 2025.

The Company facilitates several regional voluntary supply chain financing ("SCF") programs with financial institutions, all of which have similar characteristics. The Company establishes these SCF programs to provide its suppliers with a potential source of liquidity and to enable a more efficient payment process. Under these SCF programs, qualifying suppliers may elect, but are not obligated, to sell their receivables due from Amcor to these financial institutions in advance of the agreed payment due date. The Company is not involved in negotiations between the suppliers and the financial institutions, and its rights and obligations to its suppliers are not impacted by its suppliers’ decisions to sell amounts to the financial institutions. Under these SCF programs, the Company agrees to pay the financial institution the stated invoice amounts from its participating suppliers on the original maturity dates of the invoices. The range of payment terms negotiated with suppliers under these arrangements are consistent with industry norms and short-term in nature, regardless of whether a supplier participates in the program. The Company's SCF programs do not include any guarantees to the financial institutions, or any assets pledged as securities.

All outstanding amounts related to suppliers participating in the SCF programs are reflected in trade payables in the Company’s unaudited condensed consolidated balance sheets, and associated payments are included in operating activities within the Company’s unaudited condensed consolidated statements of cash flows. As of December 31, 2023 and June 30, 2023, the amounts due to suppliers participating in the Company’s SCF programs amounted to $1.0 billion and $1.1 billion, respectively.

Accounting Standards Not Yet Adopted

In November 2023, the FASB issued ASU 2023-07 that adds new reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. The new standard's amendments are effective for the Company for annual periods beginning July 1, 2024, and interim periods beginning July 1, 2025, with early adoption permitted, and will be applied retrospectively to all periods in the financial statements. The Company will adopt this guidance in fiscal year 2025. The Company is currently evaluating the impact that this new guidance will have on its disclosures.

In December 2023, the FASB issued ASU 2023-09 that adds new income tax disclosure requirements, primarily related to existing income tax rate reconciliation and income taxes paid information. The new standard's amendments are effective for the Company for annual periods beginning July 1, 2025, with early adoption permitted, and should be applied either prospectively or retrospectively. The Company is currently evaluating the impact that this new guidance will have on its disclosures.

The Company considers the applicability and impact of all ASUs issued by the FASB. The Company determined at this time that all other ASUs not yet adopted are either not applicable or are not expected to have a material impact on its results of operations, financial position, and disclosures.

Note 3 - Restructuring and Other Related Activities, Net

Restructuring and other related activities, net, as reported on the unaudited condensed consolidated statements of income are summarized as follows:

Three Months Ended December 31,Six Months Ended December 31,
($ in millions)2023202220232022
Gain on disposal of Russian business, net$—$215$—$215
Restructuring and related expenses, net(24)(2)(52)(3)
Restructuring and other related activities, net$(24)$213$(52)$212

A pre-tax net gain on disposal of the Company's three manufacturing facilities in Russia ("Russian business") of $215 million was recognized in the three and six months ended December 31, 2022. The carrying value of the Russian business had previously been impaired by $90 million in the quarter ended June 30, 2022. For further information refer to Note 4, "Acquisitions and Disposals".

Refer to Note 5, "Restructuring" for information on restructuring and related expenses, net.

Note 4 - Acquisitions and Disposals

Fiscal Year 2024 - Acquisition

On September 27, 2023, the Company completed the acquisition of a small manufacturer of flexible packaging for food, home care, and personal care applications in India for a purchase consideration of $14 million plus the assumption of debt of $10 million. The acquisition is part of the Company's Flexibles reportable segment and the Company aims to complete the purchase price allocation as soon as practicable but no later than one year from the date of the acquisition.

Fiscal Year 2023 - Acquisitions

On May 31, 2023, the Company completed the acquisition of a New Zealand based leading manufacturer of state-of-the-art, automated protein packaging machines. The purchase consideration of $45 million is subject to customary post-closing adjustments. The consideration includes contingent consideration of $13 million, to be earned and paid in cash over the two years following the acquisition date, subject to meeting certain performance targets. The acquisition is part of the Company's Flexibles reportable segment and resulted in the recognition of acquired identifiable net assets of $21 million and goodwill of $24 million. Goodwill is deductible for tax purposes. The fair values of the contingent consideration, identifiable net assets acquired, and goodwill are based on the Company's best estimate as of December 31, 2023 using information available as of the acquisition date, and are considered preliminary. The Company aims to complete the purchase price allocation as soon as practicable but no later than one year from the date of the acquisition.

On March 17, 2023, the Company completed the acquisition of a 100% equity interest in a medical device packaging manufacturing site in Shanghai, China. The purchase consideration of $61 million includes contingent consideration of $20 million, to be earned and paid in cash over the three years following the acquisition date, subject to meeting certain performance targets. The acquisition is part of the Company's Flexibles reportable segment and resulted in the recognition of acquired identifiable net assets of $21 million and goodwill of $40 million. Goodwill is not deductible for tax purposes. The fair values of the contingent consideration, identifiable net assets acquired, and goodwill are based on the Company's best estimate as of December 31, 2023 using information available as of the acquisition date, and are considered preliminary. The Company aims to complete the purchase price allocation as soon as practicable but no later than one year from the date of the acquisition.

The fair value estimates for all three acquisitions in fiscal years 2024 and 2023 were based on income, market, and cost valuation methods. Pro forma information related to these acquisitions has not been presented, as the effect of the acquisitions on the Company's consolidated financial statements was not material.

Fiscal Year 2023 - Disposal

On December 23, 2022, the Company completed the sale of the Russian business after receiving all necessary regulatory approvals and cash proceeds, including receipt of closing cash balances. The sale followed the Company’s previously announced plan to pursue the orderly sale of its Russian business. The total net cash consideration received, excluding disposed cash and items settled net, was $365 million and resulted in a net pre-tax net gain of $215 million. The carrying value of the Russian business had previously been impaired by $90 million in the quarter ended June 30, 2022. The impairment charge was based on the Company's best estimate of the fair value of its Russian business, which considered the wide range of indicative bids received and uncertain regulatory environment. The net pre-tax gain on disposal of the Russian business was recorded as restructuring and other related activities, net within the condensed consolidated statements of income. The Russian business had a net carrying value of $252 million, including allocated goodwill of $46 million and accumulated other comprehensive losses of $73 million, primarily attributed to foreign currency translation adjustments.

Note 5 - Restructuring

Restructuring and related expenses, net, were $24 million and $2 million during the three months ended December 31, 2023 and 2022, respectively, and $52 million and $3 million during the six months ended December 31, 2023 and 2022, respectively. The Company's restructuring activities for the three and six months ended December 31, 2023 were primarily comprised of restructuring activities related to the 2023 Restructuring Plan (as defined below). The Company's restructuring activities in the three and six months ended December 31, 2022 related to Other Restructuring Plans (as defined below).

Restructuring related expenses are directly attributable to restructuring activities; however, they do not qualify for special accounting treatment as exit or disposal activities. The Company believes the disclosure of restructuring related costs provides more information on its restructuring activities.

2023 Restructuring Plan

On February 7, 2023, the Company announced that it will allocate approximately $110 million to $130 million of the sale proceeds from the Russian business to various cost saving initiatives to partly offset divested earnings from the Russian business (the "2023 Restructuring Plan" or the "Plan"). The Company expects the total Plan cash and non-cash net expenses to total approximately $230 million. As of December 31, 2023, the Company has initiated projects with an expected net cost of approximately $210 million, of which $87 million relates to employee related expenses, $45 million to fixed asset related expenses (net of expected gains on asset disposals), $55 million to other restructuring expenses, and $23 million to restructuring related expenses. The projects initiated as of December 31, 2023 are expected to result in approximately $110 million of net cash expenditures. The Plan includes both the Flexibles and Rigid Packaging reportable segments and is expected to be largely completed by the end of calendar year 2024.

From the initiation of the Plan through December 31, 2023, the Company has incurred $77 million in employee related expenses, $25 million in fixed asset related expenses, $27 million in other restructuring, and $13 million in restructuring related expenses, with $126 million incurred in the Flexibles reportable segment and $16 million incurred in the Rigid Packaging reportable segment. The Plan has resulted in cumulative net cash outflows of $49 million. Additional cash payments of approximately $40 million to $45 million, net of estimated proceeds from disposals, are expected for the remainder of the fiscal year 2024, the majority of which relates to the Flexibles reportable segment.

The restructuring related costs relate primarily to the closure of facilities and include startup and training costs after relocation of equipment, and other costs incidental to the Plan.

Other Restructuring Plans

The Company has entered into other individually immaterial restructuring plans ("Other Restructuring Plans"). Expenses incurred on such programs are primarily costs to move equipment and other costs.

Consolidated Restructuring Plans

The total costs incurred from the beginning of the Company's 2023 Restructuring Plan and Other Restructuring Plans are as follows:

($ in millions)2023 Restructuring Plan (1)Other Restructuring Plans (2)Total Restructuring and Related Expenses
Fiscal year 2023$94$17$111
Fiscal year 2024, first quarter26228
Fiscal year 2024, second quarter22224
Net expenses incurred$142$21$163

(1)Includes restructuring related expenses from the 2023 Restructuring Plan of $6 million, $3 million, and $4 million for fiscal year 2023, first quarter of fiscal year 2024, and second quarter of fiscal year 2024, respectively. In the three and six months ended December 31, 2023, $16 million and $39 million of restructuring and related expenses, net, were incurred in the Flexibles reportable segment and $6 million and $9 million in the Rigid Packaging reportable segment.

(2)Includes restructuring related costs of $4 million, nil, and $1 million for fiscal year 2023, first quarter of fiscal year 2024, and second quarter of fiscal year 2024, respectively.

An analysis of the restructuring charges by type incurred is as follows:

Three Months Ended December 31,Six Months Ended December 31,
($ in millions)2023202220232022
Employee related expenses$(3)$1$13$2
Fixed asset related expenses6—12—
Other expenses16—19—
Total restructuring expenses, net$19$1$44$2

An analysis of the Company's restructuring plan liability is as follows:

($ in millions)Employee CostsFixed Asset Related CostsOther CostsTotal Restructuring Costs
Liability balance as of June 30, 2023$126$3$21$150
Net charges to earnings13121944
Cash paid(40)—(18)(58)
Non-cash and other—(12)(2)(14)
Foreign currency translation1——1
Liability balance as of December 31, 2023$100$3$20$123

The table above includes liabilities arising from the 2023 Restructuring Plan and Other Restructuring Plans. The accruals related to restructuring activities have been recorded on the unaudited condensed consolidated balance sheets under other current liabilities.

Note 6 - Goodwill and Other Intangible Assets, Net

Goodwill

Changes in the carrying amount of goodwill attributable to each reportable segment were as follows:

($ in millions)Flexibles SegmentRigid Packaging SegmentTotal
Balance as of June 30, 2023$4,391$975$5,366
Acquisitions (1)1—1
Foreign currency translation20121
Balance as of December 31, 2023$4,412$976$5,388

(1)Acquisitions are attributed to goodwill recognized in connection with the business combinations detailed in Note 4, "Acquisitions and Disposals".

Goodwill is not amortized but is tested for impairment annually in the fourth quarter of the fiscal year, or during interim periods if events or circumstances arise which indicate that goodwill may be impaired.

Other Intangible Assets, Net

Other intangible assets, net were comprised of the following:

December 31, 2023
($ in millions)Gross Carrying AmountAccumulated Amortization and Impairment (1)Net Carrying Amount
Customer relationships$2,006$(729)$1,277
Computer software272(187)85
Other (2)339(227)112
Total other intangible assets$2,617$(1,143)$1,474
June 30, 2023
($ in millions)Gross Carrying AmountAccumulated Amortization and Impairment (1)Net Carrying Amount
Customer relationships$1,987$(660)$1,327
Computer software261(185)76
Other (2)327(206)121
Total other intangible assets$2,575$(1,051)$1,524

(1)Accumulated amortization and impairment as of December 31, 2023 and June 30, 2023 included $37 million and $34 million, respectively, of accumulated impairment in the Other category.

(2)As of December 31, 2023 and June 30, 2023, Other included $18 million and $17 million, respectively, of acquired intellectual property assets not yet being amortized as the related R&D projects have not yet been completed.

Amortization expenses for intangible assets were $47 million and $43 million during the three months ended December 31, 2023 and 2022, respectively, and $91 million and $87 million during the six months ended December 31, 2023 and 2022, respectively.

Note 7 - Fair Value Measurements

The fair values of the Company's financial assets and financial liabilities listed below reflect the amounts that would be received to sell the assets or paid to transfer the liabilities in an orderly transaction between market participants at the measurement date (exit price).

The Company's non-derivative financial instruments primarily include cash and cash equivalents, trade receivables, trade payables, short-term debt, and long-term debt. As of December 31, 2023 and June 30, 2023, the carrying value of these financial instruments, excluding long-term debt, approximated fair value because of the short-term nature of these instruments.

The carrying value of long-term debt with variable interest rates approximates its fair value. The fair value of the Company's long-term debt with fixed interest rates is based on market prices, if available, or expected future cash flows discounted at the current interest rate for financial liabilities with similar risk profiles.

The carrying values and estimated fair values of long-term debt with fixed interest rates (excluding the fair value of designated receive-fixed/pay-variable interest rate swaps) were as follows:

December 31, 2023June 30, 2023
Carrying ValueFair ValueCarrying ValueFair Value
($ in millions)(Level 2)(Level 2)
Total long-term debt with fixed interest rates (excluding commercial paper (1) and finance leases)$4,149$3,990$4,123$3,844

(1) As of December 31, 2023, and June 30, 2023, the Company held interest rate swap contracts for a total notional amount of commercial paper equal to $1.2 billion. These contracts are considered to be economic hedges and the related $1.2 billion notional amount of commercial paper is also excluded from the total long-term debt with fixed interest rates.

Assets and Liabilities Measured and Recorded at Fair Value on a Recurring Basis

Additionally, the Company measures and records certain assets and liabilities, including derivative instruments and contingent purchase consideration liabilities, at fair value. The following table summarizes the fair value of these instruments, which are measured at fair value on a recurring basis, by level, within the fair value hierarchy:

December 31, 2023
($ in millions)Level 1Level 2Level 3Total
Assets
Commodity contracts$—$1$—$1
Forward exchange contracts—4—4
Interest rate swaps—7—7
Total assets measured at fair value$—$12$—$12
Liabilities
Contingent purchase consideration$—$—$38$38
Commodity contracts—1—1
Forward exchange contracts—4—4
Interest rate swaps—82—82
Total liabilities measured at fair value$—$87$38$125
June 30, 2023
($ in millions)Level 1Level 2Level 3Total
Assets
Forward exchange contracts$—$3$—$3
Interest rate swaps—16—16
Total assets measured at fair value$—$19$—$19
Liabilities
Contingent purchase consideration$—$—$46$46
Commodity contracts—2—2
Forward exchange contracts—5—5
Interest rate swaps—96—96
Total liabilities measured at fair value$—$103$46$149

The fair value of the commodity contracts was determined using a discounted cash flow analysis based on the terms of the contracts and observed market forward prices discounted at a currency specific rate. Forward exchange contract fair values were determined based on quoted prices for similar assets and liabilities in active markets using inputs such as currency rates and forward points. The fair value of the interest rate swaps was determined using a discounted cash flow method based on market based swap yield curves, taking into account current interest rates.

Contingent purchase consideration liabilities arise from business acquisitions and other investments. As of December 31, 2023, the Company had contingent purchase consideration liabilities of $38 million, consisting of $27 million of contingent purchase consideration predominantly relating to fiscal year 2023 acquisitions (refer to Note 4, "Acquisitions and Disposals") and a $11 million liability that is contingent on future royalty income generated by Discma AG, a subsidiary acquired in March 2017. The fair values of the contingent purchase consideration liabilities were determined for each arrangement individually. The fair values were determined using an income approach with significant inputs that are not observable in the market. Key assumptions include the selection of discount rates consistent with the level of risk of achievement and probability adjusted financial projections. The expected outcomes are recorded at net present value, which require adjustment over the life for changes in risks and probabilities. Changes arising from modifications in forecasts related to contingent consideration are not expected to be material. During the three and six months ended December 31, 2023, income of $9 million was recorded in other income/(expenses), net from remeasuring the fair value of the Company's contingent purchase consideration liability.

The fair value of contingent purchase consideration liabilities is included in other current liabilities and other non-current liabilities in the unaudited condensed consolidated balance sheets.

Assets and Liabilities Measured and Recorded at Fair Value on a Nonrecurring Basis

In addition to assets and liabilities that are recorded at fair value on a recurring basis, the Company records certain assets at fair value on a nonrecurring basis, generally when events or changes in circumstances indicate the carrying value may not be recoverable, or when they are deemed to be other than temporarily impaired. These assets include goodwill and other intangible assets, equity method and other investments, long-lived assets and disposal groups held for sale, and other long-lived assets. The fair values of these assets are determined, when applicable, based on valuation techniques using the best information available, and may include quoted market prices, market comparables, and discounted cash flow projections. These nonrecurring fair value measurements are considered to be Level 3 in the fair value hierarchy.

During the three months ended December 31, 2023 and 2022, there were no impairment charges recorded on indefinite-lived intangibles, including goodwill. For information on long-lived asset impairments, refer to Note 5, "Restructuring".

Note 8 - Derivative Instruments

The Company periodically uses derivatives and other financial instruments to hedge exposures to interest rates, commodity prices, and currency risks. The Company does not hold or issue derivative instruments for speculative or trading purposes. For hedges that meet hedge accounting criteria, the Company, at inception, formally designates and documents the instruments as a fair value hedge or a cash flow hedge of a specific underlying exposure. On an ongoing basis, the Company assesses and documents that its designated hedges have been and are expected to continue to be highly effective.

Interest Rate Risk

The Company's policy is to manage exposure to interest rate risk by maintaining a mixture of fixed-rate and variable-rate debt, monitoring global interest rates, and, where appropriate, hedging floating interest rate exposure or debt at fixed interest rates through various interest rate derivative instruments including, but not limited to, interest rate swaps, cross-currency interest rate swaps, and interest rate locks. For interest rate swaps that are accounted for as fair value hedges, the gains and losses related to the changes in the fair value of the interest rate swaps are included in interest expense and offset changes in the fair value of the hedged portion of the underlying debt that are attributable to the changes in market interest rates. Changes in the fair value of interest rate swaps that have not been designated as hedging instruments are reported in the accompanying unaudited condensed consolidated statements of income in other income/(expenses), net.

In March 2023, the Company entered into interest rate swap contracts for a total notional amount of $1.2 billion. Under the terms of the contracts, the Company pays a weighted-average fixed interest rate of 3.88% and receives a variable rate of interest, based on 1-month Term Secured Overnight Financing Rate ("SOFR"), from July 2023 through June 2024, settled monthly. As of December 31, 2023 and June 30, 2023, the Company had no other receive-variable/pay-fixed interest rate swaps. Although the Company is not applying hedge accounting, the Company believes that these economic hedging instruments are effective in protecting the Company against the risks of changes in the variable interest rate on a portion of its forecasted commercial paper issuances.

As of December 31, 2023, and June 30, 2023, the total notional amount of the Company’s receive-fixed/pay-variable interest rate swaps was $650 million.

Foreign Currency Risk

The Company manufactures and sells its products and finances operations in a number of countries throughout the world and, as a result, is exposed to movements in foreign currency exchange rates. The purpose of the Company's foreign currency hedging program is to manage the volatility associated with the changes in exchange rates.

To manage this exchange rate risk, the Company utilizes forward contracts. Contracts that qualify for hedge accounting are designated as cash flow hedges of certain forecasted transactions denominated in foreign currencies. The effective portion of the changes in fair value of these instruments is reported in accumulated other comprehensive loss ("AOCI") and reclassified into earnings in the same financial statement line item and in the same period or periods during which the related hedged transactions affect earnings. The ineffective portion is recognized in earnings over the life of the hedging relationship in the same consolidated statements of income line item as the underlying hedged item. Changes in the fair value of forward contracts that have not been designated as hedging instruments are reported in the accompanying unaudited condensed consolidated statements of income.

As of December 31, 2023, and June 30, 2023, the notional amount of the outstanding forward contracts was $450 million and $462 million, respectively.

Commodity Risk

Certain raw materials used in the Company's production processes are subject to price volatility caused by weather, supply conditions, political and economic variables, and other unpredictable factors. The Company's policy is to minimize exposure to price volatility by passing through the commodity price risk to customers, including through the use of fixed price swaps.

In some cases, the Company purchases, on behalf of customers, fixed price commodity swaps to offset the exposure of price volatility on the underlying sales contracts. These instruments are cash closed out on maturity and the related cost or benefit is passed through to customers. Information about commodity price exposure is derived from supply forecasts submitted by customers and these exposures are hedged by central treasury units. Changes in the fair value of commodity hedges are recognized in AOCI. The cumulative amount of the hedge is recognized in the unaudited condensed consolidated statements of income when the forecasted transaction is realized.

The Company had the following outstanding commodity contracts to hedge forecasted purchases:

December 31, 2023June 30, 2023
CommodityVolumeVolume
Aluminum14,670 tons14,325 tons
PET resin16,600,000 lbs.— lbs.

The following table provides the location of derivative instruments in the unaudited condensed consolidated balance sheets:

($ in millions)Balance Sheet LocationDecember 31, 2023June 30, 2023
Assets
Derivatives in cash flow hedging relationships:
Commodity contractsOther current assets$1$—
Forward exchange contractsOther current assets32
Derivatives not designated as hedging instruments:
Forward exchange contractsOther current assets11
Interest rate swapsOther current assets716
Total current derivative contracts1219
Total non-current derivative contracts——
Total derivative asset contracts$12$19
Liabilities
Derivatives in cash flow hedging relationships:
Commodity contractsOther current liabilities$1$2
Forward exchange contractsOther current liabilities23
Derivatives not designated as hedging instruments:
Forward exchange contractsOther current liabilities11
Total current derivative contracts46
Derivatives in cash flow hedging relationships:
Forward exchange contractsOther non-current liabilities—1
Derivatives in fair value hedging relationships:
Interest rate swapsOther non-current liabilities8296
Derivatives not designated as hedging instruments:
Forward exchange contractsOther non-current liabilities1—
Total non-current derivative contracts8397
Total derivative liability contracts$87$103

Certain derivative financial instruments are subject to master netting arrangements and are eligible for offset. The Company has made an accounting policy election not to offset the fair values of these instruments within the unaudited condensed consolidated balance sheets.

The following tables provide the effects of derivative instruments on AOCI and in the unaudited condensed consolidated statements of income:

Location of Loss Reclassified from AOCI into IncomeLoss Reclassified from AOCI into Income (Effective Portion)
Three Months Ended December 31,Six Months Ended December 31,
($ in millions)2023202220232022
Derivatives in cash flow hedging relationships
Commodity contractsCost of sales$—$(4)$(1)$(2)
Forward exchange contractsNet sales(1)(1)—(1)
Treasury locksInterest expense——(1)(1)
Total$(1)$(5)$(2)$(4)
Location of Gain / (Loss) Recognized in the Unaudited Condensed Consolidated Statements of IncomeGain / (Loss) Recognized in Income for Derivatives Not Designated as Hedging Instruments
Three Months Ended December 31,Six Months Ended December 31,
($ in millions)2023202220232022
Derivatives not designated as hedging instruments
Forward exchange contractsOther income/(expenses), net$6$10$8$(5)
Interest rate swapsOther income/(expenses), net(6)1(9)1
Total$—$11$(1)$(4)
Location of Gain/(Loss) Recognized in the Unaudited Condensed Consolidated Statements of IncomeGain/(Loss) Recognized in Income for Derivatives in Fair Value Hedging Relationships
Three Months Ended December 31,Six Months Ended December 31,
($ in millions)2023202220232022
Derivatives in fair value hedging relationships
Interest rate swapsInterest expense$25$5$14$(28)
Total$25$5$14$(28)

Note 9 - Components of Net Periodic Benefit Cost

Net periodic benefit cost for defined benefit plans included the following components:

Three Months Ended December 31,Six Months Ended December 31,
($ in millions)2023202220232022
Service cost$5$5$9$9
Interest cost12122524
Expected return on plan assets(14)(14)(28)(28)
Amortization of actuarial loss1—21
Amortization of prior service credit(1)(1)(2)(2)
Settlement costs——1—
Net periodic benefit cost$3$2$7$4

Service cost is included in operating income. All other components of net periodic benefit cost are recorded within other non-operating income, net.

Note 10 - Income Taxes

The provision for income taxes for the three and six months ended December 31, 2023 and 2022 is based on the Company’s estimated annual effective tax rate for the respective fiscal years, and is applied on income before income taxes and equity in loss of affiliated companies, and is adjusted for specific items that are required to be recognized in the period in which they are incurred.

The effective tax rate for the three months ended December 31, 2023 increased by 10.3 percentage points compared to the three months ended December 31, 2022 from 6.7% to 17.0%, primarily due to the difference in the magnitude of discrete events in both periods, mainly driven by tax benefits attributable to the disposal of the Russian business in the three months ended December 31, 2022.

The effective tax rate for the six months ended December 31, 2023 increased by 7.1 percentage points compared to the six months ended December 31, 2022 from 11.6% to 18.7%, primarily due to the difference in the magnitude of discrete events in both periods, mainly driven by tax benefits attributable to the disposal of the Russian business in the six months ended December 31, 2022.

Note 11 - Shareholders' Equity

The changes in ordinary and treasury shares during the six months ended December 31, 2023 and 2022 were as follows:

Ordinary SharesTreasury Shares
(shares and $ in millions)Number of SharesAmountNumber of SharesAmount
Balance as of June 30, 20221,489$152$(18)
Share buyback / cancellations(3)———
Options exercised and shares vested——(18)221
Purchase of treasury shares——18(221)
Balance as of December 31, 20221,486$152$(18)
Balance as of June 30, 20231,448$141$(12)
Share buyback / cancellations(3)———
Shares vested——(4)49
Purchase of treasury shares——4(48)
Balance as of December 31, 20231,445$141$(11)

The changes in the components of accumulated other comprehensive loss, net of tax, during the six months ended December 31, 2023 and 2022 were as follows:

Foreign Currency TranslationNet Investment HedgePensionEffective DerivativesTotal Accumulated Other Comprehensive Loss
($ in millions)
Balance as of June 30, 2022$(892)$(13)$40$(15)$(880)
Other comprehensive loss before reclassifications(91)——(6)(97)
Amounts reclassified from accumulated other comprehensive loss74—(1)376
Net current period other comprehensive loss(17)—(1)(3)(21)
Balance as of December 31, 2022$(909)$(13)$39$(18)$(901)
Balance as of June 30, 2023$(823)$(13)$(10)$(16)$(862)
Other comprehensive income before reclassifications31——132
Amounts reclassified from accumulated other comprehensive loss——123
Net current period other comprehensive income31—1335
Balance as of December 31, 2023$(792)$(13)$(9)$(13)$(827)

The following tables provide details of amounts reclassified from AOCI into income:

Three Months Ended December 31,Six Months Ended December 31,
($ in millions)2023202220232022
Amortization of pension:
Amortization of prior service credit$(1)$(1)$(2)$(2)
Amortization of actuarial loss1—21
Effect of pension settlement——1—
Total before tax effect—(1)1(1)
Tax effect————
Total net of tax$—$(1)$1$(1)
Losses on cash flow hedges:
Commodity contracts$—$4$1$2
Forward exchange contracts11—1
Treasury locks——11
Total before tax effect1524
Tax effect—(1)—(1)
Total net of tax$1$4$2$3
Losses on foreign currency translation:
Foreign currency translation adjustment$—$74$—$74
Total before tax effect—74—74
Tax effect————
Total net of tax$—$74$—$74

Forward contracts to purchase own shares

The Company's employee share plans require the delivery of shares to employees in the future when rights vest or vested options are exercised. The Company currently acquires shares on the open market to deliver shares to employees to satisfy vesting or exercising commitments which exposes the Company to market price risk.

To protect the Company from share price volatility, the Company entered into forward contracts for the purchase of its ordinary shares. As of December 31, 2023, the Company had forward contracts outstanding that were entered into in September 2022 and mature in March 2024 to purchase 6 million shares at a weighted average price of $12.11. As of June 30, 2023, the Company had forward contracts outstanding that were entered into in May 2022 and September 2022 that mature between September 2023 and November 2023 to purchase 9 million shares at a weighted average price of $12.39. During the six months ended December 31, 2023, forward contracts related to 3 million shares were settled, which were outstanding as of June 30, 2023.

The forward contracts to purchase the Company's own shares have been included in other current liabilities in the unaudited condensed consolidated balance sheets. Equity is reduced by an amount equal to the fair value of the shares at inception. The carrying value of the forward contracts at each reporting period was determined based on the present value of the cost required to settle the contracts.

Note 12 - Segments

The Company's business is organized and presented in the two reportable segments outlined below:

Flexibles: Consists of operations that manufacture flexible and film packaging in the food and beverage, medical and pharmaceutical, fresh produce, snack food, personal care, and other industries. The results of the Russian business sold on December 23, 2022 are included in the comparative period results until the date of sale.

Rigid Packaging: Consists of operations that manufacture rigid containers for a broad range of predominantly beverage and food products, including carbonated soft drinks, water, juices, sports drinks, milk-based beverages, spirits and beer, sauces, dressings, spreads and personal care items, and plastic caps for a wide variety of applications.

Other consists of the Company's undistributed corporate expenses including executive and functional compensation costs, equity method and other investments, intercompany eliminations, and other business activities.

The accounting policies of the reportable segments are the same as those in the unaudited condensed consolidated financial statements. Intersegment sales and transfers are not significant.

The following table presents information about reportable segments:

Three Months Ended December 31,Six Months Ended December 31,
($ in millions)2023202220232022
Flexibles$2,481$2,812$5,049$5,591
Rigid Packaging7708301,6451,763
Other————
Net sales$3,251$3,642$6,694$7,354
Adjusted earnings before interest and taxes ("Adjusted EBIT")
Flexibles$312$353$634$706
Rigid Packaging5157113123
Other(11)(11)(38)(38)
Adjusted EBIT352399709791
Less: Amortization of acquired intangible assets from business combinations (1)(43)(40)(83)(80)
Less: Impact of hyperinflation (2)(34)(5)(51)(13)
Add/(Less): Restructuring and other related activities, net (3)(24)207(52)204
Add/(Less): Other (4)(9)1(13)2
Interest income11112120
Interest expense(89)(79)(174)(138)
Equity in loss of affiliated companies, net of tax1—2—
Income before income taxes and equity in loss of affiliated companies$165$494$359$786

(1)Amortization of acquired intangible assets from business combinations includes amortization expenses related to all acquired intangible assets from past acquisitions.

(2)Impact of hyperinflation includes the adverse impact of highly inflationary accounting for subsidiaries in Argentina where the functional currency was the Argentine Peso.

(3)Restructuring and other related activities, net includes incremental costs incurred in connection with the Russia-Ukraine conflict in fiscal year 2023.

(4)Other includes various expense and income items relating to acquisitions, retroactive foil duties, certain litigation reserve settlements, and fair value movements on economic hedges.

The following tables disaggregate net sales by geography in which the Company operates based on manufacturing or selling operations:

Three Months Ended December 31,
20232022
($ in millions)FlexiblesRigid PackagingTotalFlexiblesRigid PackagingTotal
North America$951$549$1,500$1,092$623$1,715
Latin America265221486269207476
Europe864—8641,030—1,030
Asia Pacific401—401421—421
Net sales$2,481$770$3,251$2,812$830$3,642
Six Months Ended December 31,
20232022
($ in millions)FlexiblesRigid PackagingTotalFlexiblesRigid PackagingTotal
North America$1,975$1,225$3,200$2,198$1,349$3,547
Latin America550420970554414968
Europe1,722—1,7221,985—1,985
Asia Pacific802—802854—854
Net sales$5,049$1,645$6,694$5,591$1,763$7,354

Note 13 - Earnings Per Share Computations

The Company applies the two-class method when computing its earnings per share ("EPS"), which requires that net income per share for each class of share be calculated assuming all of the Company's net income is distributed as dividends to each class of share based on their contractual rights.

Basic EPS is computed by dividing net income available to ordinary shareholders by the weighted-average number of ordinary shares outstanding after excluding the ordinary shares to be repurchased using forward contracts. Diluted EPS includes the effects of share options, restricted share units, performance rights, performance shares, and share rights, if dilutive.

Three Months Ended December 31,Six Months Ended December 31,
(in millions, except per share amounts)2023202220232022
Numerator
Net income attributable to Amcor plc$134$459$286$691
Distributed and undistributed earnings attributable to shares to be repurchased(1)(3)(1)(6)
Net income available to ordinary shareholders of Amcor plc—basic and diluted$133$456$285$685
Denominator
Weighted-average ordinary shares outstanding1,4441,4861,4451,485
Weighted-average ordinary shares to be repurchased by Amcor plc(5)(11)(6)(11)
Weighted-average ordinary shares outstanding for EPS—basic1,4391,4751,4391,474
Effect of dilutive shares110111
Weighted-average ordinary shares outstanding for EPS—diluted1,4401,4851,4401,486
Per ordinary share income
Basic earnings per ordinary share$0.093$0.309$0.198$0.465
Diluted earnings per ordinary share$0.092$0.307$0.198$0.461

Note: Per share amounts are computed independently for each of the quarters presented. The sum of the quarters may not equal the total year amount due to the impact of changes in average quarterly shares outstanding and all other quarterly amounts may not equal the total year due to rounding.

Certain stock awards outstanding were not included in the computation of diluted earnings per share above because they would not have had a dilutive effect. The excluded stock awards for the three and six months ended December 31, 2023 represented an aggregate of 35 million and 31 million shares, respectively. The excluded stock awards for the three and six months ended December 31, 2022 represented an aggregate of 15 million and 12 million shares, respectively.

Note 14 - Contingencies and Legal Proceedings

Contingencies - Brazil

The Company's operations in Brazil are involved in various governmental assessments and litigation, principally related to claims for excise and income taxes. The Company vigorously defends its positions and believes it will prevail on most, if not all, of these matters. The Company does not believe that the ultimate resolution of these matters will materially impact the Company's consolidated results of operations, financial position, or cash flows. Under customary local regulations, the Company's Brazilian subsidiaries may need to post cash or other collateral if a challenge to any administrative assessment proceeds to the Brazilian court system; however, the level of cash or collateral already pledged or potentially required to be pledged would not significantly impact the Company's liquidity. As of December 31, 2023, the Company has recorded accruals of $14 million, included in other non-current liabilities in the unaudited condensed consolidated balance sheets. The Company has estimated a reasonably possible loss exposure in excess of the recorded accrual of $27 million as of December 31, 2023. The litigation process is subject to many uncertainties and the outcome of individual matters cannot be accurately predicted. The Company routinely assesses these matters as to the probability of ultimately incurring a liability and records the best estimate of the ultimate loss in situations where the likelihood of an ultimate loss is probable. The Company's assessments are based on its knowledge and experience, but the ultimate outcome of any of these matters may differ from the Company's estimates.

As of December 31, 2023, the Company provided letters of credit of $17 million, judicial insurance of $2 million, and deposited cash of $14 million with the courts to continue to defend the cases referenced above.

Contingencies - Environmental Matters

The Company, along with others, has been identified as a potentially responsible party ("PRP") at several waste disposal sites under U.S. federal and related state environmental statutes and regulations and may face potentially material environmental remediation obligations. While the Company benefits from various forms of insurance policies, actual coverage may not, or may only partially, cover the total potential exposures. As of December 31, 2023, the Company has recorded aggregate accruals of $9 million for its share of estimated future remediation costs at these sites.

In addition to the matters described above, as of December 31, 2023, the Company has also recorded aggregate accruals of $52 million for potential liabilities for remediation obligations at various worldwide locations that are owned or operated by the Company, or were formerly owned or operated.

The SEC requires the Company to disclose certain information about proceedings arising under federal, state, or local environmental provisions if the Company reasonably believes that such proceeding may result in monetary sanctions above a stated threshold. Pursuant to SEC regulations, the Company uses a threshold of $1 million or more for purposes of determining whether disclosure of any such proceedings is required. Applying this threshold, there are no environmental matters required to be disclosed for the three and six months ended December 31, 2023.

While the Company believes that its accruals are adequate to cover its future obligations, there can be no assurance that the ultimate payments will not exceed the accrued amounts. Nevertheless, based on the available information, the Company does not believe that its potential environmental obligations will have a material adverse effect upon its liquidity, results of operations, or financial condition.

Other Matters

In the normal course of business, the Company is subject to legal proceedings, lawsuits, and other claims. While the potential financial impact with respect to these ordinary course matters is subject to many factors and uncertainties, management believes that any financial impact to the Company from these matters, individually and in the aggregate, would not have a material adverse effect on the Company's financial position or results of operations.

Note 15 - Subsequent Events

On February 6, 2024, the Company's Board of Directors declared a quarterly cash dividend of $0.1250 per share to be paid on March 19, 2024 to shareholders of record as of February 28, 2024. Amcor has received a waiver from the Australian Securities Exchange ("ASX") settlement operating rules, which will allow Amcor to defer processing conversions between ordinary share and CHESS Depositary Instrument ("CDI") registers from February 27, 2024 to February 28, 2024, inclusive.

On February 6, 2024, the Company's Board of Directors extended the approval for the remaining $39 million of ordinary shares and CDIs of the $100 million buyback until June 30, 2024.

Previous: Cover and table of contents · Next: Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations